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157 The routine annual review chest X-ray (CXR) in CF − is it useful?
D. Nazareth1, P. Milburn-McNulty1, G.H. Jones1, S.M.H. Kazmi1, J. Greenwood1,
M.J. Ledson1, M.J. Walshaw1. 1Liverpool Adult CF Unit, Liverpool, United
Kingdom
Objectives: An Annual Review, including a chest X-ray (CXR), is mandatory for
all CF patients to ensure that treatment of their complex disease is optimized. Since
the CXR involves potentially harmful ionizing radiation, we assessed the value of
its routine use at annual assessment.
Methods: We looked at 65 adult CF patients who had undergone a CXR solely as
part of their annual review and compared the results with previous radiological and
clinical parameters, looking for potential changes in management.
Results: The results are summarised in the table. Only 2 (3%) had new ﬁndings
that altered clinical management: one with new patchy airspace changes and one
with bronchial mucus plugging. Both cases were well with no change in symptoms
or other objective clinical parameters dictating a modiﬁcation in treatment. The
remaining patients had unchanged CXR appearances, were clinically stable, and
did not require any alteration in management.
Conclusions: This study illustrates the low yield of signiﬁcant ﬁndings of routine
chest radiological imaging in adult CF patients with stable disease, questioning
whether this potentially harmful investigation should still be mandated at annual
review.
Clinical Parameters and Microbiology
Males (n = 38) Females (n = 27)
Age (years) [SD] 29 (11) 27 (10)
FEV1% predicted (SD) 82 (23) 90 (17)
FVC % predicted (SD) 99 (18) 106 (13)
CFRD (%) 26 4
Transmissible Pseudomonas (%) 39 15
Other Pseudomonas (%) 24 33
Burkholderia cepacia (%) 11 0
158 Helical chest CT in cystic ﬁbrosis: comparison of standard-dose
and simulated low-dose techniques
N. Gosset1, J. Gosset2, P. Scillia2, V. De Maertelaer3, C. Knoop4, D. Tack5,
P.-A. Gevenois1. 1Erasme University Hospital, Radiology, Brussels, Belgium;
2Centre Hospitalier Tivoli, Radiology, La Louvie`re, Belgium; 3Erasme University
Hospital, Biostatistics and Medical Informatics, Brussels, Belgium; 4Hoˆpital
Erasme, Chest Medicine, Bruxelles, Belgium; 5RHMS Baudour, Radiology,
Baudour, Belgium
Purpose: To test the hypothesis that radiation dose delivered by helical chest CT
could be reduced in adults with cystic ﬁbrosis (CF).
Materials and Methods: Raw data from 88 CT scans (44 at full-inspiration and
44 at full-expiration) at 120 KV and a quality reference effective tube current
time product of 90mAs in 22 women and 22 men with CF (mean age, 29 years
±7 [standard deviation]) were reconstructed with 1-mm-thick sections at 10-mm
intervals at standard-dose and simulated reduced dose (i.e. 20% of standard mAs
setting). At both doses, two independent readers scored the presence, extent, and
severity of bronchiectasis, mucus plugging, airway wall thickening, parenchymal
abnormalities on inspiratory scans. Air trapping was scored on expiratory scans.
Scores for each lobe and each abnormality, as well as a global score were calculated
and compared between doses by using analyses of variance for repeated measures
with regard to two factors (dose and reader) and at two levels for each factor.
Results: No dose effect was detected for scores per lobe (P ranging from 0.164
to 0.830) and for global score (P = 0.179). A reader effect was detected for scores
on all lobes (P ranging from 0.004 to <0.001) but two (P = 0.142 and 0.481) and
for global score (P< 0.001). A dose effect was observed for parenchymal changes
and air trapping (P< 0.001), but not for other ﬁndings (P ranging from 0.099 to
0.250) while a reader effect was detected for all ﬁndings (P< 0.001) except for
parenchymal abnormalities (P = 0.531).
Conclusion: In CF adults, mAs setting can be reduced to 20% of standard setting
at full inspiration, but not for full expiration.
159 Lung Clearance Index (LCI) during and following a pulmonary
exacerbation (PEx) in patients with CF
K. O’Neill1, E. Johnston1, M. Tunney1, J.S. Elborn1, J.M. Bradley2. 1Queen’s
University Belfast, CF & Airways Microbiology Research Group, Belfast, United
Kingdom; 2University of Ulster, Health and Rehabilitation Sciences Research
Institute, Belfast, United Kingdom
Introduction: LCI has been reported to be a useful measure of lung function during
PEx in children and adults with CF [1,2].
Objective: To assess the change in LCI and FEV1 during and after a PEx.
Methods: Patients admitted to the adult CF centre for treatment of a PEx were
recruited. The Respiratory and Systemic Symptoms Questionnaire (RSSQ), Multi-
ple Breath Washout (MBW) test and spirometry were completed at initiation and
completion of intravenous (IV) antibiotic treatment and at 4 weeks post treatment
when patients were clinically stable. Participants completed 3 MBW tests, using
0.2% SF6 and a modiﬁed Innocor
TM device. LCI was reported as the mean of 2
acceptable tests. Spirometry was performed to ATS/ERS standards.
Results: To date, 7 patients (4M:3F), mean age (SD) 32.3 (14.8) have been
recruited. All patients had a PEx as deﬁned by RSSQ (4/12 signs or symptoms
on RSSQ) on admission. Two patients did not complete the follow-up visit. From
initiation to completion of IV antibiotic treatment, both LCI and FEV1 improved in
6/7 patients. FEV1 improved by a median (range) 17% (−5 to 42%), LCI decreased
by a median (range) −0.6 (−4.6 to 0.6) lung turnovers. In contrast, from completion
of treatment to 4 weeks post treatment (clinically stable) both LCI (n = 5/5) and
FEV1 (n = 4/5) deteriorated. FEV1 decreased by a median (range) −3% (−3 to 14%)
whilst LCI increased by a median (range) 1.1 (0.9 to 2.1) lung turnovers.
Conclusion: These results show that LCI can be used to demonstrate changes in
lung function during and post antibiotic treatment of a PEx.
Reference(s)
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160 Lung Clearance Index: short term tracking in patients with CF
F. Vermeulen1, J. Ophoff1, M. Proesmans1, K. De Boeck1. 1University of Leuven,
Pediatric Pulmonology, Leuven, Belgium
Objectives: Lung clearance index (LCI) is a sensitive measure of small airway
function, the site of early CF lung disease. In cross sectional studies, abnormal LCI
correlates with bronchiectasis detected on chest CT scan. In short term studies LCI
is responsive to intervention. However more studies on tracking and responsiveness
are needed. The aim of this study was to evaluate the visit to visit variability of
LCI and the relationship between changes in LCI and changes in clinical status in
CF patients.
Methods: LCI was measured prior to spirometry in 17 patients with CF using the
Ecomedics set up for nitrogen washout. Treating physicians blinded to the LCI
results determined the CF clinical score (CFCS) (Kanga). The same measurements
were taken at a subsequent clinical visit.
Results: At ﬁrst visit (baseline) mean age was 12.6 yrs (sd 3.4), mean FEV1% pred
91.4% (sd 19.5), mean LCI 11.8 (sd 3.6) and mean CFCS 16.7 (sd 4.4). Baseline
LCI correlated with CFCS (r = 0.831; p< 0.001) and FEV1% pred (r = −0.715,
p< 0.001). Mean time between clinic visits was 127 days (sd 58). Change in
LCI correlated with change in CFCS (r = 0.535, p = 0.027) but not with change
in FEV1% pred (r = −0.320, p = 0.157). In patients with stable CFCS ( difference
baseline and repeat score 4; n = 7) mean change in LCI was 0.51 (sd 1.63).
Conclusions: LCI correlated with CFCS and FEV1. Changes in LCI correlated
with changes in CFCS but not with changes in FEV1% pred. In patients with
stable condition LCI variability between clinic visits was small.
